CEOInterviews.AI
Verified executive transcripts, quotes, and interview insights from Lyell Immunopharma leadership.
Clinical-stage T-cell reprogramming company developing CAR T therapies for solid tumors and blood cancers. [BIOTECH-2026-10-04]
Search transcripts, quotes, and verified statements from every Lyell Immunopharma executive via our platform or API.